Citation Impact

Citing Papers

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
First-in-human trial of blood–brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound
2019
Differential expression analysis for sequence count data
2010 Standout
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma
2017
Phase II Pilot Study of Bevacizumab in Combination with Temozolomide and Regional Radiation Therapy for Up-Front Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Interim Analysis of Safety and Tolerability
2008
IDH1andIDH2Mutations in Gliomas
2009 Standout
The WHO Classification of Tumors of the Nervous System
2002 Standout
GTI: A Novel Algorithm for Identifying Outlier Gene Expression Profiles from Integrated Microarray Datasets
2011
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Results of a Survey of Neurosurgical Practice Patterns Regarding the Prophylactic use of Anti-Epilepsy Drugs in Patients with Brain Tumors
2005
Glioblastoma and Other Malignant Gliomas
2013 Standout
Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion
1992
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Synthesis and self-assembly of a mikto-arm star dual drug amphiphile containing both paclitaxel and camptothecin
2014
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
2004 Standout
Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2015
Inhibition of angiogenesis and invasion in malignant gliomas
2007
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas
2004
mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients
2011
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Epigenetics in Cancer
2008 Standout
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI
2019 StandoutNobel
Slow Glucose Removal Rate and Hyperinsulinemia Precede the Development of Type II Diabetes in the Offspring of Diabetic Parents
1990
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
2019
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Medical management of patients with brain tumors
2006
Malignant Gliomas in Adults
2008 Standout
Carboplatin: current status and future prospects
1988
Prevention of Venous Thromboembolism
2004 Standout
Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial
2005 Standout
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
2020 Standout
Current and future developments in the use of temozolomide for the treatment of brain tumours
2001
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Myocardial Reperfusion Injury
2007 Standout
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research
2001
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
2020 StandoutNature
Patterns of left ventricular dilation during the six months after myocardial infarction
1989
Prevention of Venous Thromboembolism
2008 Standout
Primary brain tumours in adults
2012 Standout
Does reperfusion injury exist in humans?
1993
Identification of human brain tumour initiating cells
2004 StandoutNature
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
The role of matrix metalloproteinases in the pathophysiology and progression of human nervous system malignancies: a chance for the development of targeted therapeutic approaches?
2008
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
Single‐cell sequencing maps gene expression to mutational phylogenies in PDGF ‐ and EGF ‐driven gliomas
2016
Management of glioblastoma: State of the art and future directions
2020 Standout
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Primary Prevention of Ischemic Stroke
2001
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Angiogenesis as a Therapeutic Target in Malignant Gliomas
2009
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
2004 Standout
Effect of fatty acids on glucose production and utilization in man.
1983
Carotid Stenting and Angioplasty
1998
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma
2007
Management of Venous Thromboembolism in Patients With Primary and Metastatic Brain Tumors
2006
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
2020 StandoutScience
Mitochondrial Dysfunction and Type 2 Diabetes
2005 StandoutScience
Primary Prevention of Ischemic Stroke
2001
Role of Insulin Resistance in Human Disease
1988 Standout
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor
2019 StandoutNobel
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Cancerous stem cells can arise from pediatric brain tumors
2003 Standout
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing
2020 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Comparison of coronary angiographic findings in acute and chronic first presentation of ischemic heart disease.
1993
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout

Works of James Perry being referenced

Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
2010
Consensus Against Both Endarterectomy and Routine Screening for Asymptomatic Carotid Artery Stenosis
1997
Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study
2019
Isolated Candida infection of the lung
2015
Gliadel Wafers in the Treatment of Malignant Glioma: A Systematic Review
2007
The risk of venous thromboembolism is increased throughout the course of malignant glioma
2000
Acute leukemia following treatment of malignant glioma
1998
NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94)
2000
Thromboembolic disease in patients with high-grade glioma
2012
Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial
2004
Demonstration of myocardial reperfusion injury in humans: Results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction
1991
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
2010
PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma
2010
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma and methylated O6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Key results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study.
2013
Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation★
2006
Can surveying practitioners about their practices help identify priority clinical practice guideline topics?
2003
Standards of care for treatment of recurrent glioblastoma—are we there yet?
2012
Current Treatment of Oligodendrogliomas
1999
A Citywide Prehospital Protocol Increases Access to Stroke Thrombolysis in Toronto
2009
Challenges in the design and conduct of phase III brain tumor therapy trials
1997
Characterization and Immunogenicity of a Novel Mosaic M HIV-1 gp140 Trimer
2014
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
2016
Determinants of left ventricular aneurysm formation after anterior myocardial infarction: A clinical and angiographic study
1986
HYPERGLYCEMIA PER SE (INSULIN AND GLUCAGON WITHDRAWN) CAN INHIBIT HEPATIC GLUCOSE PRODUCTION IN MAN
1979
Abstract 301: Galectin-1 modulates PI3 kinase activity
2010
The temozolomide RESCUE study: A phase II trial of continuous (28/28) dose-intense temozolomide (TMZ) after progression on conventional 5/28 day TMZ in patients with recurrent malignant glioma
2008
Systematic Review of the Diagnosis and Management of Malignant Extradural Spinal Cord Compression: The Cancer Care Ontario Practice Guidelines Initiative‘s Neuro-Oncology Disease Site Group
2005
Rankless by CCL
2026